Zoetis Inc. (ZTS) — Stock Valuation & Research

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted…

ZTS key statistics

Price$72.22
Market cap$30.27B
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNYSE
52-week range71-148.79
Dividend (TTM)$2.09 per share
Beta0.73

Explore ZTS's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.